ADRM1
Proteasomal ubiquitin receptor ADRM1
Also known as: ADRM1_HUMAN, ARM1, GP110, PSMD16, Rpn13
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16186
- Gene
- ADRM1
- Ensembl
- ENSG00000130706
- Chromosome
- 20
- Canonical length
- 407 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a member of the adhesion regulating molecule 1 protein family. The encoded protein is a component of the proteasome where it acts as a ubiquitin receptor and recruits the deubiquitinating enzyme, ubiquitin carboxyl-terminal hydrolase L5. Increased levels of the encoded protein are associated with increased cell adhesion, which is likely an indirect effect of this intracellular protein. Dysregulation of this gene has been implicated in carcinogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
407 residues, UniProt reviewed canonical sequence.
>Q16186|ADRM1
1 MTTSGALFPS LVPGSRGASN KYLVEFRAGK MSLKGTTVTP DKRKGLVYIQ QTDDSLIHFC
61 WKDRTSGNVE DDLIIFPDDC EFKRVPQCPS GRVYVLKFKA GSKRLFFWMQ EPKTDQDEEH
121 CRKVNEYLNN PPMPGALGAS GSSGHELSAL GGEGGLQSLL GNMSHSQLMQ LIGPAGLGGL
181 GGLGALTGPG LASLLGSSGP PGSSSSSSSR SQSAAVTPSS TTSSTRATPA PSAPAAASAT
241 SPSPAPSSGN GASTAASPTQ PIQLSDLQSI LATMNVPAGP AGGQQVDLAS VLTPEIMAPI
301 LANADVQERL LPYLPSGESL PQTADEIQNT LTSPQFQQAL GMFSAALASG QLGPLMCQFG
361 LPAEAVEAAN KGDVEAFAKA MQNNAKPEQK EGDTKDKKDE EEDMSLDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADRM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 376 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 376 nTPM
- testis: 130 nTPM
- liver: 121 nTPM
- heart muscle: 111 nTPM
- esophagus: 102 nTPM
- skin: 96 nTPM
Single-cell type
- late spermatids: 2,560 nCPM
- syncytiotrophoblasts: 525 nCPM
- esophageal apical cells: 417 nCPM
- early spermatids: 376 nCPM
- cytotrophoblasts: 282 nCPM
- esophageal basal cells: 248 nCPM
Immune cell
- naive B-cell: 267 nTPM
- T-reg: 267 nTPM
- intermediate monocyte: 262 nTPM
- memory B-cell: 261 nTPM
- total PBMC: 261 nTPM
- eosinophil: 234 nTPM
Brain region
- medulla oblongata: 76 nTPM
- pons: 74 nTPM
- hypothalamus: 69 nTPM
- cerebellum: 68 nTPM
- cerebral cortex: 67 nTPM
- thalamus: 66 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.38
- DepMap mean gene effect
- -0.33
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- proteasome assembly
- proteasome-mediated ubiquitin-dependent protein catabolic process
- transcription elongation by RNA polymerase II
Molecular functions
- endopeptidase activator activity
- molecular function inhibitor activity
- protease binding
- proteasome binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DEUBAD domain
- Proteasomal ubiquitin receptor Rpn13/ADRM1
- RPN13, DEUBAD domain
- RPN13, DEUBAD domain superfamily
- Proteasomal ubiquitin receptor Rpn13/ADRM1, Pru domain superfamily
- Rpn13/ADRM1, Pru domain
- Proteasome complex subunit Rpn13, Pru domain
- UCH-binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADRM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADRM1 as an antibody target. Whether an autoantibody or antibody against ADRM1 could matter depends on whether native ADRM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADRM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ADRM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...